Bausch + Lomb (BLCO) earnings

Healthcare · Medical Instruments & Supplies · Market cap $6.1B

In the quarter ended June 2026, Bausch + Lomb had revenue of $1.4B, up 9.1% on a year earlier, and diluted EPS of -0.04.

On July 29, 2026 it reported EPS of 0.16 against an estimate of 0.16 (matched).

The next report is expected on Wednesday, October 28, 2026 before the market opens, with EPS expected around 0.21.

Report dates

ReportDateTimeEPS estimateEPS reported
NextWed Oct 28, 2026 Before open 0.21 —
LastWed Jul 29, 2026 — 0.16 0.16

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Quarterly results

The last 12 quarters from Bausch + Lomb's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Jun 30, 2026$1.4B +9.1% -0.04 — 6.0% 2026-07-29
Mar 31, 2026$1.2B +9.4% -0.20 — 2.7% 2026-04-29
Dec 31, 2025$1.4B +9.8% — — 8.0% 2026-02-18
Sep 30, 2025$1.3B +7.1% -0.08 -900.0% 7.4% 2025-10-29
Jun 30, 2025$1.3B +5.1% -0.18 — -0.9% 2025-07-30
Mar 31, 2025$1.1B +3.5% -0.60 — -7.3% 2025-04-30
Dec 31, 2024$1.3B +9.1% — — 6.8% 2025-02-19
Sep 30, 2024$1.2B +18.8% 0.01 — 3.6% 2024-10-30
Jun 30, 2024$1.2B +17.5% -0.43 — 2.1% 2024-08-01
Mar 31, 2024$1.1B +18.0% -0.48 — 0.5% 2024-05-01
Dec 31, 2023$1.2B +17.8% — — 4.2% 2024-02-21
Sep 30, 2023$1.0B +6.9% -0.24 — 4.0% 2023-11-01
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BLCO.
Open BLCO in Investingly

Questions

When does Bausch + Lomb report earnings?

Bausch + Lomb's next earnings report is expected on October 28, 2026 before the market opens.

How did Bausch + Lomb do last quarter?

In the quarter ended June 2026, Bausch + Lomb had revenue of $1.4B, up 9.1% on a year earlier, and diluted EPS of -0.04.

From Bausch + Lomb's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.